Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.700
+0.050 (3.03%)
At close: May 22, 2026, 4:00 PM EDT
1.730
+0.030 (1.76%)
After-hours: May 22, 2026, 7:56 PM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $452.44 million as of May 22, 2026. Its market cap has increased by 25.93% in one year.
Market Cap
452.44M
Enterprise Value
577.65M
1-Year Change
25.93%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $452.44M, a decrease of -53.34%. That is a compound annual growth rate of -9.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 452.44M | -14.57% |
| Dec 31, 2025 | 529.63M | -15.31% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adlai Nortye | 476.80M |
| Shattuck Labs | 467.75M |
| Eupraxia Pharmaceuticals | 458.60M |
| Upstream Bio | 455.50M |
| Ocugen | 453.62M |
| 4D Molecular Therapeutics | 449.58M |
| Neurogene | 437.87M |
| Sagimet Biosciences | 437.82M |